Table 3.
Univariate Analysis of the Factors Associated with RE
| Characteristics | HR | 95% CI | p-value |
|---|---|---|---|
| CD4/CD8 | 1.88 | 0.71~6.96 | 0.201 |
| HGB | 4.25 | 1.43~13.73 | 0.011 |
| ALB | 2.33 | 0.95~5.83 | 0.066 |
| Uxiliary/induced T cells | 0.40 | 0.06~1.70 | 0.259 |
| History of hypertension | 3.57 | 1.24~10.90 | 0.020 |
| Age | 2.27 | 0.90~6.18 | 0.092 |
| History of abdominal/pelvic surgery | 0.84 | 0.21~2.94 | 0.797 |
| History of diabetes | 1.17 | 0.28~ 4.44 | 0.817 |
| Concurrent chemotherapy | 0.64 | 0.27~ 1.51 | 0.306 |
| Induction chemotherapy | 0.84 | 0.31~2.09 | 0.708 |
| External radiation dose | 0.45 | 0.18~1.08 | 0.079 |
| Inhibitory/cytotoxic T cells | 1.88 | 0.71~4.96 | 0.201 |
| Iinternal brachytherapy | 1.61 | 0.58~4.97 | 0.381 |
| Total B lymphocyte count | 1.56 | 0.61~4.29 | 0.366 |
| Total T lymphocyte count | 2.4 | 0.97~6.29 | 0.064 |
| Small intestine V45 | 0.60 | 0.23~1.49 | 0.278 |
| Sigmoid colon V45 | 0.41 | 0.15~1.03 | 0.066 |
| Rectum V45 | 1.23 | 0.52~2.94 | 0.637 |
| Sigmoid colon D2cc | 0.47 | 0.12~1.47 | 0.219 |
| Rectum D2cc | 0.34 | 0.05~1.45 | 0.190 |